Skip to main content
Journal of Patient-Reported Outcomes
Fig. 1 | Journal of Patient-Reported Outcomes

Fig. 1

From: Are changes in patient-reported outcomes prognostic for diffuse large B-Cell lymphoma survival? Results from the GOYA trial

Fig. 1

Risk of Progression-Free Survival When Measured by Change in EORTC QLQ-C30 Score and FACT-Lym LymS Score, Respectively, From Baseline to Cycle 3 Day 1 in the Study Sample (N = 1,132). Abbreviations: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; HR, hazard ratio; QOL, quality of life; FACT-Lym LymS, Functional Assessment of Cancer Therapy-Lymphoma Lymphoma Subscale

Back to article page